1. Glypican-3 is a prognostic factor and an immunotherapeutic target in hepatocellular carcinoma
   Yukihiro Haruyama, 2016, World Journal of Gastroenterology CrossRef
2. Next-Generation Cancer Immunotherapy Targeting Glypican-3
   Yasuhiro Shimizu et al, 2019, Frontiers in Oncology CrossRef